Background: Butyrate, a fermentation product of intestinal bacteria, modifies chromatin structure through histone acetylation, thereby altering gene transcription. 
Introduction
The small intestinal epithelium regulates the absorption of nutrients and also serves as a barrier to the external environment (1) . Epithelial cells may also participate actively in host defense mechanisms (2) . They express class II major histocompatibility complex (MHC) molecules and they secrete chemokines in response to invasive pathogens (3, 4) . The location of the intestinal epithelium between the luminal environment containing bacterial products and the immunocytes of the mucosal lamina propria puts it in a strategic position to respond quickly to changes in the external environment to maintain host equilibrium.
Luminal short-chain fatty acids, such as acetate, propionate, and butyrate, are the principal products of bacterial fermentation of ingested carbohydrates (5) in the gastrointestinal tract. The concentrations of short-chain fatty acids largely depend on dietary intake and on the types of bacteria present (6) . Short-chain fatty acids are not present in the intestinal lumen before birth, but reach adult levels by the age of 1 year (7) . Among the short-chain fatty acids, butyrate is the principal source of energy for colonocytes. Butyrate also has a stimulatory effect on epithelial cell proliferation in vivo (8) , which contributes to epithelial cell restitution and integrity. Butyrate concentrations are higher in the large intestine (5-24 mM) (5, 9) than in the small intestine. However, concentrations of butyrate in the intestine increase significantly with bacterial overgrowth, as seen in short bowel syndrome and stagnant loops (10) . Butyrate concentration is also increased in intestinal inflammation as seen in infants with necrotizing enterocolitis (1 1) and in patients with Crohn's disease (9) . Because short-chain fatty acid concentrations reflect bacterial colonization, they may alter the secretion of cytokines that control inflammation. Intestinal epithelial cells synthesize and secrete a number of chemokines, including interleukin-8 (IL-8) (3) and monocyte chemoattractant protein-I (MCP-1) (12) . and MCP-1 are two potent members of a family of at least 30 distinct [8] [9] [10] [11] [12] [13] [14] kD chemokines. Their genes are located at chromosomes 4 and 17, respectively. IL-8 has chemotactic and activating properties for neutrophils. MCP-1 attracts and activates monocytes. We have shown that butyrate enhances the secretion of IL-8 by intestinal epithelial (Caco-2) cells stimulated with IL-13 (13) . Its action on MCP-1 secretion has not been reported.
Changes in histone acetylation affect gene transcription by altering the charge on histones such that nucleosomes become less compact (14) (15) (16) . Butyrate inhibits histone deacetylase activity, resulting in the increased acetylation of histones. The consequent destabilization on certain genes has been examined using DNase I sensitivity of defined regions of chromatin (17, 18) . We hypothesized, therefore, that shortchain fatty acids regulate IL-8 and MCP-1 expression and that this regulation involves histone acetylation. After 24 hr incubation with either butyrate (5 mM), trichostatin-A (10 ,uM), or media alone, cells were removed and the nuclear protein harvested by centrifuging in MLB buffer (60 mM KCI/15 mM NaCl/3 mM MgCl2/15 mM piperazine-N/N' bis{2 ethanesulfonic acid), pH 6.5/0.1% Nonidet P-40/0.5 mM phenyl methyl sulfonyl fluoride/I mM tetrathionate). The nuclear pellet was suspended in H2SO4 to a final concentration of 0.2 M for 2 hr. The suspension was centrifuged and the supernatants containing the histones removed. The dissolved histones were precipitated with alcohol at -200C. The precipitant was suspended in water, quantified, and 50 ,g of each sample loaded onto a triton X-acetic acid-urea gel for histone separation. Gels were stained with Coumassie blue and destained in methanol and acetic acid. The position of the histone-4 was identified with a histone-4 marker (Boehringer Mannheim). In addition to butyrate, the effect of other short-chain fatty acids and that of trichostatin-A, a histone deacetylase inhibitor (22) , on histone acetylation were determined. Each of these reagents was given for 24 hr before adding IL-1(3 to the media.
Materials and Methods

Statistics
Differences between sets of wells were examined by analysis of variance, using the Gabriel test for multiple comparisons. Results with a probability of <0.05 were considered significant. Fig. 1) . This reflects the secretion of chemokines from epithelial cells in vivo (12) . Butyrate increased the secretion of IL-8 in a dose-dependent manner. However, butyrate decreased the production of MCP-1 (Fig. 1) . Thus, butyrate, a bacterial fermentation product, regulated the expression of IL-8 and MCP-1 by intestinal epithelial cells in different directions. In the absence of butyrate, LPS had no effect on IL-8 and MCP-1 secretion by Caco-2 cells (Fig. 2) . However, with butyrate, LPS induced the secretion of IL-8, as previously described (13) . In cells stimulated with LPS, butyrate also increased IL-8 and decreased MCP-1 secretion (Fig. 2) .
Results
IL-1,3 is a proinflammatory cytokine synthesized and secreted by macrophages in the intestinal mucosa during inflammation. IL-1i3 activated intestinal epithelial cells to secrete IL-8 and MCP-1 in increased amounts (Fig. 3) . Again, butyrate increased IL-8 secretion and decreased MCP-1 secretion. Butyrate had a marked effect on chemokine secretion because IL-1,B produced a strong stimulatory response on both chemokines. The differential regulation of butyrate on IL-8 and MCP-1, therefore, did not depend on whether cells were stimulated by LPS or IL-13 or had received no proinflammatory stimuli.
Butyrate Differentially Alters IL-8 and MCP-1 mRNA Accumulation in IL-1 3-Stimulated Caco-2 Cells To exclude the possibility that the differential effects of butyrate acted on the translation of chemokine mRNA or on a post-translational mechanism (such as chemokine secretion), we examined MCP-1 and IL-8 mRNA accumulation (Fig. 4) . RNA was collected after 24 hr of butyrate (0-5 mM) followed by 2 (Fig. 7) . The effect of each short-chain fatty acid on chemokine expression was simultaneously studied. Propionate, butyrate, and valerate altered the pattern of IL-8 and MCP-1 secretion (Fig. 7) . Moreover, they altered chemokine secretion according to the degree by which histones were acetylated (Fig. 7) . In our experiments, we examined the effects of the bacterial product butyrate on IL-8 and MCP-1 production in the cultured intestinal epithelial cell line Caco-2. Butyrate increased the secretion of IL-8 by Caco-2 cells and decreased the production of MCP-1 (Fig. 1) in a dose-dependent fashion. Moreover, when the cells were subsequently stimulated with IL-13, a proinflammatory cytokine secreted by macrophages in response to inflammatory stimuli, a marked differential response of IL-8 and MCP-1 was observed (Fig. 3) . Similar patterns were observed in the accumulation of mRNA for both of these chemokines (Fig. 4) In our experiments (Fig. 1) , the changes in IL-8 and MCP-1 were small in the absence of a proinflammatory stimulus. This is consistent with the observation that short-chain fatty acids do not normally induce neutrophil in vivo [except at high concentrations (26) where, in mice, inflammatory changes were observed]. On the other hand, the increase in IL-8 production in cells (Fig. 3) receiving a proinflammatory stimulus was large in the presence of butyrate. Thus, only in the presence of inflammation would butyrate markedly alter epithelial cell IL-8 expression. The increased butyrate concentrations reported in both Crohn's colitis (9) and necrotizing enterocolitis (1 1) may therefore contribute to the inflammatory changes.
We examined IL-8 secretion into the lumen in normal subjects with no evidence of intestinal inflammation (27). Rectal dialysates were collected by inserting bags made from dialysis tubing for 4 hr. Low levels of IL-8 were detected in the dialysate. However, similar experiments performed on patients with colitis showed greater IL-8 secretion. The IL-8 collected induced neutrophil activation. Short-chain fatty acid enemas have been used therapeutically in patients with diversion colitis (28) and distal ulcerative colitis with limited success (29) , but they have not been beneficial to patients with Crohn's disease. Instead, elemental diets that are low in fiber (an important substrate for short-chain fatty acids) trophil activation. Short-chain fatty acid enemas have been used therapeutically in patients with diversion colitis (28) and distal ulcerative colitis with limited success (29) , but they have not been beneficial to patients with Crohn's disease. Instead, elemental diets that are low in fiber (an important substrate for short-chain fatty acids) decrease Crohn's disease activity (30) and reverse growth retardation in children (31) . This observation is consistent with the assertion that butyrate may enhance inflammation in Crohn's disease. Furthermore, the benefits of short-chain fatty acids in ulcerative colitis do not conflict with the data presented in this report. Butyrate is a nutrient of the colonic epithelial cell; it reduces epithelial permeability (32) and facilitates salt and water absorption in the colon. Ulcerative colitis is characterized by changes in epithelial cell morphology and often loss of surface epithelial cells. At early stages of the disease, when injury to epithelial cells is greatest, the benefit of butyrate is statistically significant (33) .
The effects of butyrate on cultured epithelial cells were reversible (Fig. 6) , both in terms of histone acetylation and their effects on the inhibition of MCP-1. The stimulation of IL-8 by butyrate was also reversed (R.D. Fusunyan et al., unpublished data). These data support the assertion that the changes observed with short-chain fatty acids were an active response, and not the result of cell damage. Furthermore, the distinct direction in which the two chemokines alter makes apoptosis (34) or other causes of cell death an unlikely trigger for these phenomena.
The switching of chemokines from IL-8 to MCP-1 by butyrate was mimicked by trichostatin-A (Fig. 5) . This compound has no chemical similarity to short-chain fatty acids. It is 1000-fold more potent than butyrate in inhibiting histone deacetylase (22) . At the concentrations at which trichostatin-A induced the same effect on histone acetylation as butyrate, it induced a similar response in chemokine regulation (Fig. 5) . In addition, other short-chain fatty acids varied the expression of chemokines according to their ability to induce histone acetylation (Fig. 7) . We also investigated the effect of glutamine, another intestinal epithelial cell nutrient. Glutamine had no effect on IL-8 production by Caco-2 cells. The effects of short-chain fatty acids, therefore, were specific and not related to the delivery of energy to the epithelial cell. Furthermore, IL-1(3 alone did not induce histone acetylation (unpublished data). These data, therefore, support the hypothesis that short-chain fatty acids switch chemokine expression through their effects on histone acetylation. Nevertheless, demonstrating that histone acetylation alters chemokine secretion does not exclude other mechanisms of gene regulation involving regulatory elements of chemokine promoters. Stability of RNA could, in theory, also be altered by butyrate; however, butyrate did not alter the stability of mRNA for another chemokine, macrophage inflammatory protein-2, in a rat intestinal epithelial cell line (35) .
Evidence is accumulating that chromosomal proteins are important in regulating transcription (36) . Recently, the involvement of histone tails in binding to DNA has been inferred from experiments in which histones have been thermally denatured (37) . In vivo, changes in the charges of histones are normally the result of acetylation. The hydrogen atom in the free lysine group of the histones is normally substituted by an acetyl group. This reduces the net positive charge on the histone molecule, resulting indirectly in the destabilization of the chromatin structure (38) .
The question arises as to how butyrate can have distinct effects on different genes. The variability of butyrate in increasing transcription in any particular gene can be explained by the proximity of the gene to a "scaffold attachment region" (39) . Such regions, rich in AT sequences, form the basis by which DNA is bound to nonchromosomal structures in the nucleus. Studies on plasmids containing the IFNf3 gene (40) linked to a scaffold attachment sequence showed that close proximity to such a sequence results in a much greater sensitivity of transcription to butyrate. In this case, adding scaffold attachment sequences to the DNA containing the IFN,3 gene increased the enhancing effect from 2-fold to 80-fold. Inhibition of gene expression, however, cannot be explained by the involvement of scaffold attachment regions, and different mechanisms responsible for the down-regulation of MCP-1 must be inferred. It has been suggested that butyrate may inhibit genes whose promoters include a KB sequence (41) , by up-regulating the inhibitor IKB. However, changes in IKB cannot explain the distinct effects of butyrate on IL-8 and MCP-1 because the promoters of both genes contain a KB element. Regulation through NFKB should, therefore, induce changes in expression in the same direction. IL-1 3, for example, acts through the KB site; and both IL-8 and MCP-1 are up-regulated by its actions (Figs. 1  and 3 ). It seems likely, therefore, that an as-yet unidentified inhibitor is up-regulated by butyrate and acts on the MCP-1 promoter.
In conclusion, we have shown for the first time that butyrate switches the expression of chemokines by intestinal epithelial cells. Its effects are mediated through histone acetylation. We believe we have defined a mechanism in human intestinal epithelial cells by which resident bacteria may regulate inflammatory processes within the intestine.
